1. Home
  2. CVAC vs VZLA Comparison

CVAC vs VZLA Comparison

Compare CVAC & VZLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • VZLA
  • Stock Information
  • Founded
  • CVAC 2000
  • VZLA 2017
  • Country
  • CVAC Germany
  • VZLA Canada
  • Employees
  • CVAC N/A
  • VZLA N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • VZLA
  • Sector
  • CVAC Health Care
  • VZLA
  • Exchange
  • CVAC Nasdaq
  • VZLA Nasdaq
  • Market Cap
  • CVAC 764.4M
  • VZLA 649.3M
  • IPO Year
  • CVAC 2020
  • VZLA N/A
  • Fundamental
  • Price
  • CVAC $5.44
  • VZLA $3.29
  • Analyst Decision
  • CVAC Buy
  • VZLA Strong Buy
  • Analyst Count
  • CVAC 3
  • VZLA 3
  • Target Price
  • CVAC $9.00
  • VZLA $3.83
  • AVG Volume (30 Days)
  • CVAC 2.1M
  • VZLA 2.8M
  • Earning Date
  • CVAC 08-14-2025
  • VZLA 07-18-2025
  • Dividend Yield
  • CVAC N/A
  • VZLA N/A
  • EPS Growth
  • CVAC N/A
  • VZLA N/A
  • EPS
  • CVAC 0.87
  • VZLA N/A
  • Revenue
  • CVAC $566,039,775.00
  • VZLA N/A
  • Revenue This Year
  • CVAC N/A
  • VZLA N/A
  • Revenue Next Year
  • CVAC $24.04
  • VZLA N/A
  • P/E Ratio
  • CVAC $6.34
  • VZLA N/A
  • Revenue Growth
  • CVAC 787.60
  • VZLA N/A
  • 52 Week Low
  • CVAC $2.37
  • VZLA $1.67
  • 52 Week High
  • CVAC $5.72
  • VZLA $3.66
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 68.03
  • VZLA 57.90
  • Support Level
  • CVAC $4.07
  • VZLA $3.41
  • Resistance Level
  • CVAC $5.58
  • VZLA $3.61
  • Average True Range (ATR)
  • CVAC 0.20
  • VZLA 0.16
  • MACD
  • CVAC 0.07
  • VZLA -0.03
  • Stochastic Oscillator
  • CVAC 83.08
  • VZLA 45.65

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About VZLA Vizsla Silver Corp.

Vizsla Silver Corp is a junior mineral exploration and development company focused on advancing its Panuco silver-gold project located in Sinaloa, Mexico. The property contains quartz-carbonate veins with workings defining both steeply plunging and sub-horizontal ore shoots. Mineralization occurs as silver sulphides including argentite and acanthite, native gold, electrum and native silver associated with pyrite, minor galena, sphalerite and rare chalcopyrite. It has one operating segment, which is principally mineral exploration.

Share on Social Networks: